Blood Cancer Journal http://feeds.nature.com/bcj/rss/current Nature Publishing Group en © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Blood Cancer Journal © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. permissions@nature.com Blood Cancer Journal https://www.nature.com/uploads/product/bcj/rss.gif http://feeds.nature.com/bcj/rss/current <![CDATA[Genetically determined telomere length and risk for haematologic diseases: results from large prospective cohorts and Mendelian Randomization analysis]]> https://www.nature.com/articles/s41408-024-01035-5 Blood Cancer Journal, Published online: 18 March 2024; doi:10.1038/s41408-024-01035-5

Genetically determined telomere length and risk for haematologic diseases: results from large prospective cohorts and Mendelian Randomization analysis]]>
Yang LiJia ChenTing SunYunfei ChenRongfeng FuXiaofan LiuFeng XueWei LiuMankai JuXinyue DaiHuan DongHuiyuan LiWentian WangYing ChiLei Zhang doi:10.1038/s41408-024-01035-5 Blood Cancer Journal, Published online: 2024-03-18; | doi:10.1038/s41408-024-01035-5 2024-03-18 Blood Cancer Journal 10.1038/s41408-024-01035-5 https://www.nature.com/articles/s41408-024-01035-5
<![CDATA[Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval]]> https://www.nature.com/articles/s41408-024-01029-3 Blood Cancer Journal, Published online: 18 March 2024; doi:10.1038/s41408-024-01029-3

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval]]>
Ayalew TefferiAnimesh Pardanani doi:10.1038/s41408-024-01029-3 Blood Cancer Journal, Published online: 2024-03-18; | doi:10.1038/s41408-024-01029-3 2024-03-18 Blood Cancer Journal 10.1038/s41408-024-01029-3 https://www.nature.com/articles/s41408-024-01029-3
<![CDATA[Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?]]> https://www.nature.com/articles/s41408-024-01027-5 Blood Cancer Journal, Published online: 18 March 2024; doi:10.1038/s41408-024-01027-5

Treatment-emergent mutations in myelodysplastic syndrome with del(5q) – lenalidomide related or disease-intrinsic clonal evolution?]]>
Mostafa AbdallahKaaren ReichardNaseema GangatAyalew Tefferi doi:10.1038/s41408-024-01027-5 Blood Cancer Journal, Published online: 2024-03-18; | doi:10.1038/s41408-024-01027-5 2024-03-18 Blood Cancer Journal 10.1038/s41408-024-01027-5 https://www.nature.com/articles/s41408-024-01027-5
<![CDATA[Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry]]> https://www.nature.com/articles/s41408-024-00995-y Blood Cancer Journal, Published online: 18 March 2024; doi:10.1038/s41408-024-00995-y

Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry]]>
H. V. GilesM. T. DraysonB. KishoreC. PawlynM. KaiserG. CookR. de TuteR. G. OwenD. CairnsT. MenziesF. E. DaviesG. J. MorganG. PrattG. H. Jackson doi:10.1038/s41408-024-00995-y Blood Cancer Journal, Published online: 2024-03-18; | doi:10.1038/s41408-024-00995-y 2024-03-18 Blood Cancer Journal 10.1038/s41408-024-00995-y https://www.nature.com/articles/s41408-024-00995-y
<![CDATA[PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation]]> https://www.nature.com/articles/s41408-024-01032-8 Blood Cancer Journal, Published online: 15 March 2024; doi:10.1038/s41408-024-01032-8

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation]]>
Olaf PenackMouad AbouqatebChristophe PeczynskiWilliam BorelandZafer GülbasTobias Gedde-DahlCristina Castilla-LlorenteNicolaus KrögerMathias EderAlessandro RambaldiFrancesca BonifaziIgor Wolfgang BlauMatthias StelljesPeter DregerIvan MoiseevHélène SchoemansChristian KoeneckeZinaida Peric doi:10.1038/s41408-024-01032-8 Blood Cancer Journal, Published online: 2024-03-15; | doi:10.1038/s41408-024-01032-8 2024-03-15 Blood Cancer Journal 10.1038/s41408-024-01032-8 https://www.nature.com/articles/s41408-024-01032-8
<![CDATA[In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies]]> https://www.nature.com/articles/s41408-024-01036-4 Blood Cancer Journal, Published online: 15 March 2024; doi:10.1038/s41408-024-01036-4

In vivo expression of anti-CD19/CD3 BiTE by liver-targeted AAV for the treatment of B cell malignancies]]>
Zhiqiang SongPing LiuDongliang ZhangTao WangWenqin YueYuke GengNa LiuYang WangJianmin Yang doi:10.1038/s41408-024-01036-4 Blood Cancer Journal, Published online: 2024-03-15; | doi:10.1038/s41408-024-01036-4 2024-03-15 Blood Cancer Journal 10.1038/s41408-024-01036-4 https://www.nature.com/articles/s41408-024-01036-4
<![CDATA[Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century]]> https://www.nature.com/articles/s41408-024-01033-7 Blood Cancer Journal, Published online: 14 March 2024; doi:10.1038/s41408-024-01033-7

Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century]]>
Kari HemminkiFrantisek ZitrickyAsta FörstiMika KontroBjorn T. GjertsenMarianne Tang SeverinsenGunnar Juliusson doi:10.1038/s41408-024-01033-7 Blood Cancer Journal, Published online: 2024-03-14; | doi:10.1038/s41408-024-01033-7 2024-03-14 Blood Cancer Journal 10.1038/s41408-024-01033-7 https://www.nature.com/articles/s41408-024-01033-7
<![CDATA[Large differencies in age-specific survival in multiple myeloma in the nordic countries]]> https://www.nature.com/articles/s41408-024-01026-6 Blood Cancer Journal, Published online: 11 March 2024; doi:10.1038/s41408-024-01026-6

Large differencies in age-specific survival in multiple myeloma in the nordic countries]]>
Kari HemminkiFrantisek ZitrickyAsta FörstiRaija SilvennoinenAnnette VangstedMarkus Hansson doi:10.1038/s41408-024-01026-6 Blood Cancer Journal, Published online: 2024-03-11; | doi:10.1038/s41408-024-01026-6 2024-03-11 Blood Cancer Journal 10.1038/s41408-024-01026-6 https://www.nature.com/articles/s41408-024-01026-6